Company Profile:
Optimus Drugs Private Ltd Company Introduction:
Optimus Drugs Private Ltd is a prominent pharmaceutical company based in India. The company primarily specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. With a strong commitment to research and development, Optimus Drugs has established a robust product portfolio and advanced production capabilities. They operate multiple manufacturing facilities that adhere to international quality standards such as Good Manufacturing Practices (GMP). Optimus Drugs supplies its products to various pharmaceutical formulation companies globally, contributing significantly to the healthcare sector by providing essential raw materials for medicines.
Optimus Drugs Private Ltd is a manufacturer (factory).
Enterprise Products
Optimus Drugs Private Ltd from India primarily manufactures and sells a wide range of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Their extensive product portfolio covers several key therapeutic areas. These include various Antivirals, such as Lopinavir, Ritonavir, Favipiravir, Remdesivir, and Molnupiravir, along with APIs for the treatment of HIV and Hepatitis C. In Oncology, they produce APIs like Imatinib Mesylate, Dasatinib, Osimertinib Mesylate, and Cabozantinib S-Malate, targeting various cancers. Cardiovascular products include anticoagulants such as Apixaban, Rivaroxaban, and Ticagrelor. For Diabetes management, they offer APIs like Dapagliflozin, Empagliflozin, Semaglutide, and Sitagliptin Phosphate. Their Central Nervous System product range covers APIs for conditions like migraine, depression, and Parkinson's disease, including Lurasidone Hydrochloride and Safinamide Mesylate. They also produce a broad spectrum of Antibiotics, encompassing various generations of Cephalosporins, Penems, and novel antibacterial agents like Omadacycline Tosylate. Additionally, Optimus Drugs manufactures APIs for Gastrointestinal disorders, Respiratory conditions, and Immunosuppressants.